Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026
Market Cap 1 91.84 79.88
Change - -13.02%
Enterprise Value (EV) 1 61.1 64.14
Change - 4.98%
P/E 21.2x 19.1x
PBR 1.04x 0.86x
PEG -1.1x -5.48x
Capitalization / Revenue 1.12x 0.84x
EV / Revenue 0.74x 0.68x
EV / EBITDA 7.34x 6.31x
EV / EBIT 16x 12.6x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 1.896 1.83
Distribution rate - -
Net sales 1 82.35 94.91
EBITDA 1 8.319 10.16
EBIT 1 3.821 5.079
Net income 1 3.947 4.179
Net Debt 1 -30.75 -15.75
Reference price 2 40.24 35.00
Nbr of stocks (in thousands) 2,282 2,282
Announcement Date 26/8/25 22/8/26
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 769K
13.6x0.41x8.58x2.85% 120B
15.82x1.93x9.64x0.66% 102B
-281.44x19.63x-331.94x-.--% 58.23B
13.97x1.53x9.26x2.53% 29.08B
23.47x2.62x13.27x1.37% 26.7B
23.61x2.16x12.37x0.89% 26.68B
8.15x1.46x6.61x-.--% 21.62B
28.71x5.25x21.8x2.43% 19.58B
20.23x1.81x9.1x3.51% 18.93B
Average -14.88x 4.09x -26.81x 1.58% 42.19B
Weighted average by Cap. -24.58x 4.10x -37.04x 1.55%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Clinitech Laboratory Limited

Historical PBR trend

Valuation ratios - PBR - Clinitech Laboratory Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Clinitech Laboratory Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Clinitech Laboratory Limited

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited